Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Biodefense Market Forecast 2028 By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays and Reagents}), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: May 2022   |   Report ID: GR2113   |   Delivery: PDF  Request Free Sample

    North America Biodefense Market size exceeded USD 6.1 billion in 2021 and is anticipated to exhibit 7.5% CAGR between 2022 and 2028.

    Increasing government initiatives will drive the overall market expansion. The U.S. government is taking numerous efforts for the characterization of threat, risk assessment, medical countermeasures, detection, and surveillance of infectious disease along with laboratory protection from accidental exposures. Similarly, government is also taking initiatives for the awareness among large population base regarding bioterrorism incidences majorly in developed countries.

    North America Biodefense Market

    Get more details on this report - Request Free Sample PDF

    In bioterrorism attack, infectious viruses, bacteria, and other germs are released to cause illness, diseases. and death. Therefore, to overcome these attacks, the government is taking bio defensive measures, mainly vaccines and biothreat detection technology efforts for the safety of the population.

    North America Market, By Product

    North America Biodefense Market, By Product

    Get more details on this report - Request Free Sample PDF

    The vaccines segment accounted for USD 4 billion revenue in 2021, owing to the rising vaccine production to prevent various diseases. Surging prevalence of infectious diseases such as COVID-19, Ebola virus and Zika virus has increased the demand of vaccines. Therefore, to overcome the rising number of infectious cases researchers are inspecting new vaccine technologies including vector technology to protect against these pathogenic attacks.

    North America Market, By Country

    The U.S. biodefense market will showcase around 7.5% growth rate during the forecast period. The U.S. market consists of well-known and established firms with approved government policies within the healthcare industry. This increases the production of various vaccines for the biodefense market. The U.S. government mainly focuses on several initiatives against bioterrorism attacks with strong security measures that secures the country-level progression. Moreover, increasing adoption of advanced technological products used for biodefense purposes across the region will accelerate the market growth.

    Competitive Industry Landscape

    Some of the leading companies involved in the North America biodefense market include Bavarian Nordic, Biosearch Technologies, Alexeter Technologies, LLC, ANP Technologies, Altimmune, and BioFire Defense (bioMérieux SA).

    These market players have adopted different strategies such as launch of new products with technological advancements that have helped them in sustaining the competition and gain significant position in the industry. For instance, in February 2022, Applili Tehrapeutics Inc., received around USD 10 million in new funding from the U.S. department of defense for biodefense vaccine candidate ATI-1701. This novel strategic move will enhance the company’s progress over the analysis timeframe.

    Frequently Asked Question(FAQ) :

    How big is the North America biodefense market?
    The biodefense industry size in North America exceeded USD 6.1 billion in 2021 and is anticipated to exhibit a 7.5% CAGR between 2022 and 2028 owing to the rising number of government initiatives mainly in the U.S.
    What is biodefense?
    Biodefense are primarily medical measures, including medicines and vaccinations that protect people against bioterrorism.
    How is the biodefense industry growth driven by vaccines in North America?
    The market share for biodefense in North America from the vaccine product segment was worth USD 4 billion in revenue in 2021 and will rise with the fast-growing vaccine production for preventing various infectious diseases, including COVID-19, Ebola virus and Zika virus.
    Why is the biodefense market growing in the U.S.?
    The industry for biodefense in U.S. is set to depict growth at a rate of over 7.5% growth rate through 2028 due to the strong presence of well-known as well as established firms with approved government policies in the healthcare industry.

    Get this research report on North America Biodefense Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]